申请人:Lipford Grayson B.
公开号:US20140079724A1
公开(公告)日:2014-03-20
The present invention relates to a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same; and a method for treating or preventing autoimmunity disease using the same.
本发明涉及一种I式化合物或其药学上可接受的盐,其中符号如规范中定义;一种包含该化合物的制药组合物;以及使用该化合物治疗或预防自身免疫性疾病的方法。